ConductScience.org, home

Paper26467409

Pharmacological Approaches for Treatment-resistant Bipolar Disorder.

Hui Poon S and 2 others. Curr Neuropharmacol, 2015. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. Pharmacological Approaches for Treatment-resistant Bipolar Disorder. Papers, record 26467409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26467409

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacological Approaches for Treatment-resistant Bipolar Disorder.
PubMed
Journal
Curr Neuropharmacol
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
2.23
iCite
Revised in PubMed
2019-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hui Poon SShi
2Sim KKang
3Baldessarini RJRoss J

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antidepressive AgentsMajor topic
Bipolar DisorderMajor topic
Animals
Databases, Bibliographic
Humans

References97

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123945458A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.J Clin Psychiatry2013https://conductscience.org/library/papers/23945458PubMed
212172346Use of topiramate in treatment-resistant bipolar spectrum disorders.J Clin Psychopharmacol2002https://conductscience.org/library/papers/12172346PubMed
324737937Disturbance of the glutamatergic system in mood disorders.Exp Neurobiol2014https://conductscience.org/library/papers/24737937PubMed
422329473Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.Bipolar Disord2012https://conductscience.org/library/papers/22329473PubMed
524030475The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.Am J Psychiatry2013https://conductscience.org/library/papers/24030475PubMed
617384530Adjunctive topiramate treatment in refractory obese bipolar patients: a descriptive open label study.Eat Weight Disord2007https://conductscience.org/library/papers/17384530PubMed
723237061
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
Bipolar Disord2013https://conductscience.org/library/papers/23237061PubMed
815219473Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.Biol Psychiatry2004https://conductscience.org/library/papers/15219473PubMed
98633686Clozapine for treatment-refractory mania.Am J Psychiatry1996https://conductscience.org/library/papers/8633686PubMed
1020079890Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder.Biol Psychiatry2010https://conductscience.org/library/papers/20079890PubMed
1119823634Memantine in the management of a clinically challenging case of bipolar disorder.Indian J Psychiatry2009https://conductscience.org/library/papers/19823634PubMed
1217234318Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia.Prog Neuropsychopharmacol Biol Psychiatry2007https://conductscience.org/library/papers/17234318PubMed
1323683309Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression.Int J Neuropsychopharmacol2013https://conductscience.org/library/papers/23683309PubMed
1410386177Donepezil in treatment-resistant bipolar disorder.Biol Psychiatry1999https://conductscience.org/library/papers/10386177PubMed
1511252650Calcium channel antagonists for the treatment of bipolar disorder.Bipolar Disord2000https://conductscience.org/library/papers/11252650PubMed
1622901349Adjunctive oxycodone for the treatment of refractory bipolar depression.J Clin Psychiatry2012https://conductscience.org/library/papers/22901349PubMed
1720565433Morbidity in 303 first-episode bipolar I disorder patients.Bipolar Disord2010https://conductscience.org/library/papers/20565433PubMed
1812716249Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.J Clin Psychiatry2003https://conductscience.org/library/papers/12716249PubMed
1916649834The effects of long-term clozapine add-on therapy on the rehospitalization rate and the mood polarity patterns in bipolar disorders.J Clin Psychiatry2006https://conductscience.org/library/papers/16649834PubMed
206339106History of calcium antagonists.Circ Res1983https://conductscience.org/library/papers/6339106PubMed

See all 97 referencesDownload CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
42515799Antidepressants and Road Safety: A Forensic Toxicological Perspective Based on Observational Data and Current Evidence.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42515799PubMed
42351613Pharmacotherapeutic Options in Drug-Resistant Bipolar Depression: From Molecular Mechanisms to Rational Polypharmacotherapy.Biomedicines2026https://conductscience.org/library/papers/42351613PubMed
41799810Real-world outcomes of lurasidone augmentation for treatment-resistant bipolar depression: a retrospective observational analysis.Front Psychiatry2026https://conductscience.org/library/papers/41799810PubMed
40528728Pharmaco-psychiatry and gut microbiome: a systematic review of effects of psychotropic drugs for bipolar disorder.Microbiology (Reading)2025https://conductscience.org/library/papers/40528728PubMed
40379965Psychiatric genome-wide association study enrichment shows promise for future psychopharmaceutical discoveries.Commun Med (Lond)2025https://conductscience.org/library/papers/40379965PubMed
38515671Arginine metabolomics in mood disorders.Heliyon2024https://conductscience.org/library/papers/38515671PubMed
37963496Challenges in defining treatment-resistant mania in adults: A systematic review.Bipolar Disord2024https://conductscience.org/library/papers/37963496PubMed
37820933Bipolar mania and epilepsy pathophysiology and treatment may converge in purine metabolism: A new perspective on available evidence.Neuropharmacology2023https://conductscience.org/library/papers/37820933PubMed
37496742
Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder.
Front Neurosci2023https://conductscience.org/library/papers/37496742PubMed
37259323Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37259323PubMed
36613927Changes in T-Cell Subpopulations and Cytokine Levels in Patients with Treatment-Resistant Depression-A Preliminary Study.Int J Mol Sci2022https://conductscience.org/library/papers/36613927PubMed
36450831A repeated measures cognitive affective bias test in rats: comparison with forced swim test.Psychopharmacology (Berl)2023https://conductscience.org/library/papers/36450831PubMed
36386987Risk-to-befit ratios of consecutive antidepressants for heavy menstrual bleeding in young women with bipolar disorder or major depressive disorder.Front Psychiatry2022https://conductscience.org/library/papers/36386987PubMed
35910343Prevalence of Heavy Menstrual Bleeding and Its Associated Cognitive Risks and Predictive Factors in Women With Severe Mental Disorders.Front Pharmacol2022https://conductscience.org/library/papers/35910343PubMed
35163764Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress-Induced Damage in Patients with Bipolar Disorder.Int J Mol Sci2022https://conductscience.org/library/papers/35163764PubMed
34733182Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression.Front Psychiatry2021https://conductscience.org/library/papers/34733182PubMed
34421299Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study.Neuropsychiatr Dis Treat2021https://conductscience.org/library/papers/34421299PubMed
34356654Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders?Biomolecules2021https://conductscience.org/library/papers/34356654PubMed
34212775Presence and Severity of Mental Illness Is Associated With Increased Risk of Postoperative Emergency Visits, Readmission, and Reoperation Following Outpatient ACDF: A National Database Analysis.Global Spine J2023https://conductscience.org/library/papers/34212775PubMed
34046159Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression.Ther Adv Psychopharmacol2021https://conductscience.org/library/papers/34046159PubMed

See all 33 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCHE590PubTator's text mininghttps://conductscience.org/library/genes/590NCBI Gene
PRL5617PubTator's text mininghttps://conductscience.org/library/genes/5617NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26467409

GET https://conductscience.org/api/papers/v1/26467409/references?page=2